ASO Therapeutics: Robust Pipeline Propels Gene-Targeted Medicine Forward

ASO Therapeutics: Robust Pipeline Propels Gene-Targeted Medicine Forward

Imagine a future where genetic disorders are precisely targeted at their source. Antisense oligonucleotide therapeutics are not just a concept—they’re a rapidly advancing reality! With over 70…